1-1 of 1
Patrycja Olszynski
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I Study of XL019, a Selective JAK2 Inhibitor, in Patients with Primary Myelofibrosis, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis

Neil P. Shah, MD, PhD, Patrycja Olszynski, Lubomir Sokol, MD, PhD, Srdan Verstovsek, Ronald Hoffman, MD, Alan F. List, MD, Jorge Cortes, MD, Hagop M Kantarjian, D. Gary Gilliland, Douglas O Clary, PhD, Lynne A. Bui, MD, Martha Wadleigh, MD
Journal: Blood
Blood (2008) 112 (11): 98.
https://doi.org/10.1182/blood.V112.11.98.98
Published: 2008